These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27590804)

  • 1. Impact of Question Wording on the Measurement of Activity Limitation: Evidence From a Randomized Test in France.
    Cambois E; Grobon S; Van Oyen H; Robine JM
    J Aging Health; 2016 Oct; 28(7):1315-38. PubMed ID: 27590804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring population disability: evaluation of a new Global Activity Limitation Indicator (GALI).
    van Oyen H; Van der Heyden J; Perenboom R; Jagger C
    Soz Praventivmed; 2006; 51(3):153-61. PubMed ID: 17191540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries.
    Berger N; Van Oyen H; Cambois E; Fouweather T; Jagger C; Nusselder W; Robine JM
    BMC Med Res Methodol; 2015 Jan; 15():1. PubMed ID: 25555466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Global Activity Limitation Index measured function and disability similarly across European countries.
    Jagger C; Gillies C; Cambois E; Van Oyen H; Nusselder W; Robine JM;
    J Clin Epidemiol; 2010 Aug; 63(8):892-9. PubMed ID: 20171842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the Global Activity Limitation Indicator (GALI) to evaluate severity of disability.
    Tarazona B; González-Enríquez J; Almazán-Isla J; Alcalde-Cabero E; de Pedro-Cuesta J; Galán I
    Eur J Public Health; 2021 Jul; 31(3):539-540. PubMed ID: 33313738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Global Activity Limitation Index mainly measured functional disability, whereas self-rated health measured physical morbidity.
    Cabrero-García J; Juliá-Sanchis R
    J Clin Epidemiol; 2014 Apr; 67(4):468-76. PubMed ID: 24411314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the global activity limitation indicator in Taiwan.
    Hsiao RL; Wu CH; Hsu CW; Saito Y; Lin YH
    BMC Med Res Methodol; 2019 Mar; 19(1):52. PubMed ID: 30845914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Educational inequalities in Global Activity Limitation Indicator disability in 28 European Countries: Does the choice of survey matter?
    Rubio-Valverde JR; Nusselder WJ; Mackenbach JP
    Int J Public Health; 2019 Apr; 64(3):461-474. PubMed ID: 30478617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the global activity limitation indicator with specific measures of disability in adults aged below 65.
    Cabrero-García J; Juliá-Sanchis R; Richart-Martínez M
    Eur J Public Health; 2020 Dec; 30(6):1225-1230. PubMed ID: 32408346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the global activity limitation indicator measure participation restriction? Data from the European Health and Social Integration Survey in Spain.
    Cabrero-García J; Rico-Juan JR; Oliver-Roig A
    Qual Life Res; 2022 May; 31(5):1335-1344. PubMed ID: 34882281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the harmonisation of disability data collection in UK surveys (part 2).
    White C
    Health Stat Q; 2011; (51):31-66. PubMed ID: 21894157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring disability with parsimony.
    Verbrugge LM; Merrill SS; Liu X
    Disabil Rehabil; 1999; 21(5-6):295-306. PubMed ID: 10381242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a coherent set of indicators to monitor health across Europe: the Euro-REVES 2 project.
    Robine JM; Jagger C;
    Eur J Public Health; 2003 Sep; 13(3 Suppl):6-14. PubMed ID: 14533742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational differences in disability-free life expectancy: a comparative study of long-standing activity limitation in eight European countries.
    Mäki N; Martikainen P; Eikemo T; Menvielle G; Lundberg O; Ostergren O; Jasilionis D; Mackenbach JP;
    Soc Sci Med; 2013 Oct; 94():1-8. PubMed ID: 23931939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating disability prevalence and disability-related inequalities: Does the choice of measure matter?
    Amilon A; Hansen KM; Kjær AA; Steffensen T
    Soc Sci Med; 2021 Mar; 272():113740. PubMed ID: 33571943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of disability among adolescents and adults in rural China.
    Alhajj T; Wang L; Wheeler K; Zhao W; Sun Y; Stallones L; Xiang H
    Disabil Health J; 2010 Oct; 3(4):282-8. PubMed ID: 21122796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reports of fewer activity limitations: recovery, survey fatigue, or switching respondent?
    Hill SC; Pylypchuk Y
    Med Care; 2006 May; 44(5 Suppl):I73-81. PubMed ID: 16625067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional disability in France and its relationship with health-related quality of life - a population-based prevalence study.
    Loos-Ayav C; Chau N; Riani C; Guillemin F
    Clin Exp Rheumatol; 2007; 25(5):701-8. PubMed ID: 18078617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the harmonisation of disability data collection in UK surveys (part 1).
    White C
    Health Stat Q; 2011; (51):3-30. PubMed ID: 21894156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the prevalence of disability increased over the past decade (2000-2007) in elderly people? A Spanish population-based survey.
    Palacios-Ceña D; Jiménez-García R; Hernández-Barrera V; Alonso-Blanco C; Carrasco-Garrido P; Fernández-de-Las-Peñas C
    J Am Med Dir Assoc; 2012 Feb; 13(2):136-42. PubMed ID: 21450186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.